###begin article-title 0
Pitx2 is functionally important in the early stages of vascular smooth muscle cell differentiation
###end article-title 0
###begin p 1
###xml 33 49 33 49 <email xmlns:xlink="http://www.w3.org/1999/xlink">gko@virginia.edu</email>
Correspondence to Gary K. Owens: gko@virginia.edu
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 770 775 770 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 785 789 785 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prx1</italic>
###xml 800 805 <span type="species:ncbi:10090">mouse</span>
Mechanisms that control vascular smooth muscle cell (SMC) differentiation are poorly understood. We identify Pitx2 as a previously unknown homeodomain transcription factor that is rapidly induced in an in vitro model of SMC differentiation from multipotent stem cells. Pitx2 induces expression of multiple SMC differentiation marker genes by binding to a TAATC(C/T) cis-element, by interacting with serum response factor, and by increasing histone acetylation levels within the promoters of SMC differentiation marker genes. Suppression of Pitx2 reduces expression of SMC differentiation marker genes in the early stages of SMC differentiation in vitro, whereas Prx1, another homeodomain protein, regulates SMC differentiation marker genes in fully differentiated SMCs. Pitx2, but not Prx1, knockout mouse embryos exhibit impaired induction of SMC differentiation markers in the dorsal aorta and branchial arch arteries. Our results demonstrate that Pitx2 functions to regulate the early stages of SMC differentiation.
###end p 3
###begin p 4
Y. Shang and T. Yoshida contributed equally to this work.
###end p 4
###begin p 5
Abbreviations used in this paper: ACLP, aortic carboxypeptidase-like protein; ChIP, chromatin immunoprecipitation; E, embryonic day; EMSA, electrophoresis mobility shift assay; ES, embryonic stem; HDAC, histone deacetylase; RA, all transretinoic acid; SM, smooth muscle; SMC, SM cell; SRF, serum response factor; SSEA-1, stage-specific embryonic antigen-1.
###end p 5
###begin title 6
Introduction
###end title 6
###begin p 7
###xml 319 334 319 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">Carmeliet, 2000</xref>
###xml 336 354 336 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">Owens et al., 2004</xref>
Differentiation of smooth muscle cells (SMCs) is a critical component of formation of the cardiovascular system. During the process of arteriogenesis, endothelial cell tubes become invested with precursor cells, which subsequently differentiate into SMCs and form the medial layer of the blood vessels (for reviews see Carmeliet, 2000; Owens et al., 2004). Although the primary function of differentiated SMCs is contraction, SMCs during embryonic development also exhibit high rates of cell proliferation, migration, and production of extracellular matrix proteins that are required for vessel morphogenesis. SMC differentiation is characterized by coordinate induction of expression of a unique repertoire of SMC differentiation markers, including SM alpha-actin, SM22alpha, SM-myosin heavy chain, and h1-calponin. However, the molecular mechanisms controlling SMC differentiation during early stages of arteriogenesis are poorly understood.
###end p 7
###begin p 8
###xml 169 187 169 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">Owens et al., 2004</xref>
###xml 295 296 295 296 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 525 534 525 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myocardin</italic>
###xml 895 912 895 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">Wang et al., 2001</xref>
###xml 914 931 914 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">Chen et al., 2002</xref>
###xml 933 948 933 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">Du et al., 2003</xref>
###xml 950 970 950 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">Yoshida et al., 2003</xref>
###xml 1287 1296 1287 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myocardin</italic>
###xml 1333 1354 1333 1354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">Yoshida et al., 2004a</xref>
###xml 1356 1360 1356 1360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">2007</xref>
###xml 1362 1378 1362 1378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">Liu et al., 2005</xref>
###xml 1509 1518 1509 1518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myocardin</italic>
###xml 1666 1675 1666 1675 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myocardin</italic>
###xml 1730 1748 1730 1748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">Pipes et al., 2005</xref>
###xml 1813 1822 1813 1822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myocardin</italic>
###xml 1912 1929 1912 1929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">Wang et al., 2001</xref>
###xml 1931 1946 1931 1946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">Du et al., 2003</xref>
###xml 1623 1627 <span type="species:ncbi:10090">mice</span>
Expression of SMC differentiation markers has been shown to be controlled by a combinatorial interaction of multiple transcription factors and cofactors (for review see Owens et al., 2004). The promoter-enhancer regions of many SMC differentiation marker genes contain multiple CArG [CC(AT-rich)6GG] elements, and the transbinding factor serum response factor (SRF) and its coactivator myocardin play a key role in the regulation of these genes. Indeed, results of previous studies from our laboratory and others showed that myocardin was exclusively expressed in SMCs and cardiomyocytes and that it markedly induced the transcription of multiple CArG-containing SMC differentiation marker genes in the presence of SRF, whereas suppression of myocardin by either dominant-negative constructs or siRNA was associated with marked decreases in transcription of these genes in cultured aortic SMCs (Wang et al., 2001; Chen et al., 2002; Du et al., 2003; Yoshida et al., 2003). In addition, we showed that myocardin served as a point of convergence in mediating effects of environmental cues on expression of SMC differentiation marker genes, in that angiotensin II and platelet-derived growth factor BB regulated expression of CArG-containing SMC differentiation marker genes via changes in myocardin expression in cultured aortic SMCs (Yoshida et al., 2004a, 2007; Liu et al., 2005). However, myocardin does not appear to be required for the initial induction of SMC lineage because recent studies revealed that myocardin-null embryonic stem (ES) cells were able to differentiate into SMCs in the context of chimeric knockout mice, which were generated by injection of myocardin-null ES cells into the wild-type blastocysts in vivo (Pipes et al., 2005). Moreover, results of in situ hybridization assays showed that myocardin expression was quite low or undetectable in early developmental stages of vascular SMCs (Wang et al., 2001; Du et al., 2003). As such, although the preceding results provide compelling evidence that the CArG-SRF-myocardin complex plays a key role in the control of SMC differentiation marker gene expression in differentiated SMCs, the initial induction of SMC differentiation may not be dependent on myocardin and may be regulated through alternative molecular mechanisms.
###end p 8
###begin p 9
###xml 69 74 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prrx1</italic>
###xml 248 269 248 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">Hautmann et al., 1997</xref>
###xml 271 292 271 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">Yoshida et al., 2004a</xref>
###xml 387 391 387 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prx1</italic>
###xml 403 417 403 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 461 465 457 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prx1</italic>
###xml 523 537 519 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 653 667 645 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 1048 1071 1036 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">Bergwerff et al. [2000]</xref>
###xml 1152 1156 1140 1144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prx1</italic>
###xml 1158 1162 1146 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prx2</italic>
###xml 1167 1176 1155 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prx1/Prx2</italic>
###xml 1186 1190 <span type="species:ncbi:10090">mice</span>
Results of our previous studies have shown that Prx1 (also called as Prrx1 and MHox), a homeodomain protein, plays a key role in basal and angiotensin II-induced expression of SMC differentiation marker genes in adult differentiated SMCs in vitro (Hautmann et al., 1997; Yoshida et al., 2004a). Treatment with angiotensin II in fully differentiated cultured SMCs increased expression of Prx1 as well as SM alpha-actin. In addition, siRNA-induced suppression of Prx1 decreased basal and angiotensin II-induced expression of SM alpha-actin in differentiated SMCs. Moreover, recombinant Prx1 protein enhanced the binding of SRF to CArG elements within the SM alpha-actin promoter, although studies failed to detect the stable interaction between SRF and Prx1. These studies suggest that Prx1 is important in mediating angiotensin II-induced SMC hypertrophy in differentiated SMCs. However, there is no evidence showing that Prx1 plays a role in regulating SMC differentiation marker genes during SMC development or in SMC hypertrophy in vivo. Indeed, Bergwerff et al. [2000] found no evidence of defective SMC differentiation within developing embryos in Prx1, Prx2, or Prx1/Prx2 knockout mice. At present, there is no direct evidence that homeodomain proteins regulate SMC differentiation in vivo.
###end p 9
###begin p 10
###xml 168 182 168 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 234 256 230 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">Manabe and Owens, 2001</xref>
###xml 960 982 952 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">Manabe and Owens, 2001</xref>
We previously developed an in vitro inducible SMC differentiation lineage system derived from clonal lines of multipotential P19 embryonal carcinoma cells harboring an SM alpha-actin promoter-enhancer-driven puromycin-resistant gene (Manabe and Owens, 2001). One of these clonal lines, designated "A404," lacked expression of any known SMC differentiation marker gene under basal conditions but showed induction of all known SMC differentiation marker genes in response to treatment with all transretinoic acid (RA) and puromycin. It is of major significance that >80% of A404 cells showed induction of SM alpha-actin upon treatment with a single reagent, RA, indicating that A404 is a clonal cell line poised for induction of SMC lineage. In addition, RA-induced differentiation of A404 cells into SMCs was accompanied by increases in histone acetylation levels and SRF binding within the CArG-containing promoter regions of SMC differentiation marker genes (Manabe and Owens, 2001). Collectively, these results suggest that the A404 SMC differentiation system is a valuable model for studying early stages of induction of SMC lineage from multipotential stem cells.
###end p 10
###begin p 11
###xml 678 683 678 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 692 697 <span type="species:ncbi:10090">mouse</span>
In the present studies, we performed a subtractive hybridization screen between undifferentiated and differentiated A404 cells to identify factors critical for the initial induction of SMC differentiation. We discovered Pitx2 as a homeodomain transcription factor that was rapidly induced during the differentiation of SMCs, as compared with the delayed induction of Prx1. We show that Pitx2 induces expression of multiple SMC differentiation marker genes by binding to specific cis-regulatory elements, by interacting with SRF, and by increasing histone acetylation levels within the promoter regions of SMC differentiation marker genes. Moreover, we show that knockout of the Pitx2 gene in mouse embryos virtually abolishes the induction of SMC differentiation markers in early stages of SMC differentiation, thus providing the first evidence implicating a homeodomain protein in regulation of SMC development in vivo.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
Pitx2 expression was induced in multiple inducible culture models of SMC differentiation
###end title 13
###begin p 14
###xml 500 521 500 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">Kitamura et al., 1999</xref>
###xml 523 541 523 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">Hjalt et al., 2000</xref>
###xml 679 696 679 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">Gage et al., 1999</xref>
###xml 698 719 698 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">Kitamura et al., 1999</xref>
###xml 721 737 721 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">Lin et al., 1999</xref>
###xml 739 755 739 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">Lu et al., 1999a</xref>
###xml 942 947 942 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 1020 1028 1020 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 1047 1052 1047 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 1090 1104 1090 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 1109 1113 1105 1109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prx1</italic>
###xml 1115 1130 1111 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, B and C</xref>
###xml 1141 1146 1137 1142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 1170 1178 1166 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 D</xref>
###xml 1195 1200 1191 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 1376 1393 1372 1389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">Drab et al., 1997</xref>
###xml 1395 1413 1391 1409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">Sinha et al., 2004</xref>
###xml 1652 1657 1648 1653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 1724 1739 1720 1735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, E and F</xref>
###xml 1766 1771 1762 1767 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
To identify factors that play a key role in the initial induction of SMC differentiation, a subtractive hybridization screen was performed between undifferentiated A404 cells and differentiated A404 cells that were treated with RA for 48 h. 44 genes were found to be induced in differentiated A404 cells as compared with undifferentiated A404 cells (Table S1, available at ). Among these, Pitx2 was selected for further studies, because it is expressed in vascular SMCs during embryonic development (Kitamura et al., 1999; Hjalt et al., 2000) and it is a transcription factor implicated in the development of multiple organs such as the pituitary gland, the eyes, and the heart (Gage et al., 1999; Kitamura et al., 1999; Lin et al., 1999; Lu et al., 1999a). As an initial test of the potential importance of Pitx2 for SMC differentiation, we examined its expression in multiple inducible culture systems of SMC differentiation. Expression of Pitx2 was rapidly induced by 5.5-fold, 48 h after RA treatment in A404 cells (Fig. 1 A). The increase in Pitx2 expression preceded the induction of SM alpha-actin and Prx1 (Fig. 1, B and C), and all Pitx2 isoforms were induced (Fig. 1 D). Expression of Pitx2 was also examined in an ES cell-derived embryoid body model of SMC differentiation, which showed induction of SMC lineage in response to treatment with RA and dibutyryl cAMP (Drab et al., 1997; Sinha et al., 2004). Importantly, ES cell-derived SMCs exhibited spontaneous contraction in the context of embryoid bodies, indicating that all regulatory pathways essential for formation of contractile SMCs are present within in this system. Expression of Pitx2 was induced by sevenfold during the formation of embryoid bodies (Fig. 1, E and F). These results show that Pitx2 is induced in multiple in vitro SMC differentiation models.
###end p 14
###begin p 15
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 0 44 0 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Pitx2</italic> is induced during SMC differentiation.</bold>
###xml 191 196 189 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 202 216 200 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 226 230 220 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prx1</italic>
###xml 313 318 307 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 465 471 459 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2a</italic>
###xml 484 490 478 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2b</italic>
###xml 503 509 497 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2c</italic>
###xml 526 531 520 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH</italic>
###xml 638 643 632 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 652 666 646 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
Pitx2 is induced during SMC differentiation. (A-C) A404 cells were induced to differentiate into SMCs by treatment with 1 mug/ml RA, followed by 0.5-mug/ml puromycin treatment. Expression of Pitx2 (A), SM alpha-actin (B), and Prx1 (C) was determined by real-time RT-PCR from day (D) 0 to day 7. (D) Expression of Pitx2 isoforms was determined by semiquantitative RT-PCR in undifferentiated A404 cells and RA-treated A404 cells for 48 h. PCR products are 424 bp for Pitx2a, 297 bp for Pitx2b, 234 bp for Pitx2c, and 230 bp for GAPDH. (E and F) ES cells were induced to differentiate into SMCs in an embryoid body system, and expression of Pitx2 (E) and SM alpha-actin (F) was determined by real-time RT-PCR at days 7, 15, and 28. Values represent the mean +/- SEM of three independent experiments.
###end p 15
###begin title 16
Pitx2 was required for the induction of SMC differentiation marker genes in multiple inducible culture models of SMC differentiation
###end title 16
###begin p 17
###xml 208 222 208 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 383 397 379 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 424 432 416 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 452 466 444 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 862 876 850 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 878 887 862 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM22&#945;</italic>
###xml 893 904 873 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink">h1-calponin</italic>
###xml 985 1021 965 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aortic carboxypeptidase-like protein</italic>
###xml 1023 1027 1003 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACLP</italic>
###xml 1033 1045 1013 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink">smoothelin-B</italic>
###xml 1065 1073 1045 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 1325 1343 1305 1323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">Owens et al., 2004</xref>
To determine the role of Pitx2 in SMC differentiation, effects of overexpression of Pitx2 on SMC differentiation marker genes were examined. Expression plasmids for Pitx2 isoforms were cotransfected with the SM alpha-actin promoter-reporter construct into undifferentiated (non-RA treated) A404 cells. Results showed that each Pitx2 isoform increased transcriptional activity of the SM alpha-actin gene in a similar manner (Fig. 2 A). The induction of SM alpha-actin transcription by Pitx2 was also seen in 10T1/2 cells, although it was modest in NIH/3T3 cells (unpublished data). To determine if Pitx2 induces expression of endogenous SMC differentiation marker genes, an adenovirus expressing Flag-tagged Pitx2a was constructed. Adenovirus-mediated overexpression of Pitx2 dramatically induced expression of multiple SMC differentiation marker genes including SM alpha-actin, SM22alpha, and h1-calponin in A404 cells, although a subset of SMC differentiation marker genes, including aortic carboxypeptidase-like protein (ACLP) and smoothelin-B, were not induced (Fig. 2 B). Adenovirus-mediated overexpression of Pitx2 also increased cellular growth (Fig. S1, available at ). Although increased growth is usually associated with reduced expression of SMC differentiation markers in fully differentiated SMCs (for review see Owens et al., 2004), it is possible that enhanced growth and subsequent changes in cell density and cell-cell interactions may contribute to Pitx2-induced differentiation. However, the fact that Pitx2 selectively induced a subset of SMC differentiation marker genes suggests that this is not the case.
###end p 17
###begin p 18
###xml 0 61 0 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2 induces expression of SMC differentiation marker genes.</bold>
###xml 196 210 196 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 508 513 504 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 601 606 597 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 940 954 932 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 1029 1034 1017 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 1057 1061 1041 1045 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prx1</italic>
###xml 1260 1265 1236 1241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 1269 1273 1245 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP</italic>
Pitx2 induces expression of SMC differentiation marker genes. (A) Luciferase assays were performed in undifferentiated A404 cells cotransfected with expression plasmids for Pitx2 isoforms and the SM alpha-actin promoter-enhancer-luciferase construct. RLA, relative luciferase activity. (B) Undifferentiated A404 cells were infected with adenovirus expressing Pitx2a or empty adenovirus, and expression of SMC differentiation marker genes was determined by real-time RT-PCR. (C) Efficiency and specificity of Pitx2 siRNA were examined in COS cells cotransfected with Flag-Pitx2a expression plasmid and Pitx2 siRNA expression plasmid or control plasmids. pMighty-Empty contained no target sequence and pMighty-alphaScr targeted scrambled sequence. (D) A404 cells were induced to differentiate into SMCs by RA treatment for 1 d (early) or by RA treatment for 3 d followed by puromycin selection for 2 d (late). Cells were transfected with the SM alpha-actin promoter-enhancer-luciferase construct and a siRNA expression plasmid for Pitx2 (pMighty-alphaPitx2), Prx1 (pMighty-alphaPrx1), or pMighty-alphaScr. Luciferase assays were performed. (E and F) A404 cells were induced to differentiate into SMCs by RA treatment and were transfected with siRNA duplexes for Pitx2 or EGFP. Expression of SMC differentiation marker genes was determined by real-time RT-PCR (E) or Western blotting (F). Values represent the mean +/- SEM of three independent experiments.
###end p 18
###begin p 19
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 128 133 128 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 214 219 214 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 323 343 323 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">Yoshida et al., 2003</xref>
###xml 364 369 364 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 460 465 456 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 581 589 577 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 604 612 600 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 D</xref>
###xml 643 648 639 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 693 707 689 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 832 836 824 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prx1</italic>
###xml 858 872 850 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 968 982 956 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 995 1000 979 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 1131 1135 1115 1119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prx1</italic>
###xml 1227 1232 1211 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 1347 1361 1331 1341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 1363 1372 1343 1348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM22&#945;</italic>
###xml 1378 1389 1354 1365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">h1-calponin</italic>
###xml 1398 1402 1374 1378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACLP</italic>
###xml 1407 1419 1383 1395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">smoothelin-B</italic>
###xml 1447 1462 1423 1438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, E and F</xref>
###xml 304 309 <span type="species:ncbi:10090">mouse</span>
Effects of siRNA-induced knockdown of Pitx2 on SMC differentiation marker genes were examined in differentiated A404 cells. The Pitx2 siRNA expression plasmid, which targets a sequence that is common for all three Pitx2 isoforms, was generated in a customized pMighty system that expresses siRNA under a mouse H1 promoter (Yoshida et al., 2003). Cotransfection of Pitx2 siRNA expression plasmid (pMighty-alphaPitx2) and Pitx2a expression plasmid revealed that Pitx2 siRNA efficiently and selectively suppressed expression of Pitx2 but not expression of a nontargeted protein, SRF (Fig. 2 C). As shown in Fig. 2 D, siRNA-induced suppression of Pitx2 reduced the transcriptional activity of the SM alpha-actin gene by 70% in early time points of SMC differentiation in RA-treated A404 cells. In contrast, siRNA-induced suppression of Prx1 did not decrease the SM alpha-actin activity under these conditions. However, the reduction in the transcriptional activity of the SM alpha-actin gene by the Pitx2 siRNA was blunted at later time points of SMC differentiation in differentiated A404 cells treated with RA and puromycin, whereas Prx1 siRNA reduced the activity more effectively at the same later time points. Transfection of Pitx2 siRNA duplexes into A404 cells revealed that RA-mediated induction of SMC differentiation marker genes, including SM alpha-actin, SM22alpha, and h1-calponin but not ACLP and smoothelin-B, was attenuated by 40-60% (Fig. 2, E and F). These results suggest that Pitx2 and Prx1 play complementary roles in control of SMC differentiation marker gene expression but at different stages of SMC differentiation.
###end p 19
###begin p 20
###xml 21 30 21 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myocardin</italic>
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MKL1</italic>
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MKL2</italic>
###xml 143 148 143 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 215 229 215 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 300 309 296 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myocardin</italic>
###xml 359 363 355 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MKL1</italic>
###xml 367 368 363 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2</italic>
Expression levels of myocardin and its related factors, MKL1 and MKL2, were not altered in RA-treated A404 cells in the presence or absence of Pitx2 siRNA (Fig. S2 A, available at ). Pitx2-induced activation of the SM alpha-actin gene in A404 cells was not attenuated by siRNA-induced suppression of myocardin. However, it was partially reduced by siRNAs for MKL1 or 2 alone or in combination (Fig. S2 B). These results provide evidence that Pitx2-induced activation of SMC differentiation marker genes is not dependent on myocardin but is at least partially dependent on MKL1 and 2.
###end p 20
###begin p 21
###xml 126 134 126 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 178 183 178 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 234 239 234 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 285 307 285 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">Mortensen et al., 1992</xref>
###xml 355 360 355 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 512 520 512 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 539 544 539 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 658 676 658 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">Sinha et al., 2004</xref>
###xml 783 797 783 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 802 811 798 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM22&#945;</italic>
###xml 864 872 856 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 967 972 959 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 1048 1053 1040 1045 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 1094 1098 1086 1090 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACLP</italic>
###xml 1175 1180 1167 1172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PECAM</italic>
###xml 1182 1201 1174 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cardiac &#945;-actin</italic>
###xml 1207 1213 1195 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NeuroD</italic>
###xml 1249 1254 1237 1242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 1299 1313 1287 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 1318 1327 1302 1307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM22&#945;</italic>
###xml 1355 1360 1335 1340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 1513 1518 1493 1498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 1559 1578 1539 1558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">Semina et al., 1996</xref>
###xml 1659 1664 1635 1640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 1719 1734 1695 1710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, D and E</xref>
Loss-of-function experiments were also performed in the ES cell-derived embryoid body SMC differentiation system. As shown in Fig. 3 A, multiple independent clones of homozygous Pitx2 knockout ES cells were isolated from heterozygous Pitx2 knockout ES cells using high G418 selection (Mortensen et al., 1992). Retention of pluripotency of each homozygous Pitx2 knockout ES cell line was validated based on positive immunostaining with ES cell markers, Oct4, Sox2, and stage-specific embryonic antigen-1 (SSEA-1; Fig. 3 B). Each homozygous Pitx2 knockout cell line was then tested for its ability to differentiate into SMCs in the context of embryoid bodies (Sinha et al., 2004). In wild-type ES cell-derived embryoid bodies, expression of SMC differentiation marker genes, including SM alpha-actin and SM22alpha, was induced by 109-fold and 18-fold, respectively (Fig. 3 C). However, induction of these SMC differentiation marker genes was dramatically attenuated in Pitx2-null embryoid bodies derived from all five independent lines of homozygous Pitx2 knockout ES cells, whereas induction of ACLP expression was not affected. Expression of other lineage markers, including PECAM, cardiac alpha-actin, and NeuroD, was unaffected by deletion of the Pitx2 gene (Fig. S3, available at ). Induction of SM alpha-actin and SM22alpha expression in heterozygous Pitx2 knockout ES cells was also partially impaired, which is consistent with the fact that Axenfeld-Rieger syndrome, a disease caused by the mutation of the Pitx2 gene, is a haploinsufficiency disorder (Semina et al., 1996). Furthermore, induction of SM alpha-actin protein expression was attenuated in Pitx2-null embryoid bodies as determined by flow cytometry (Fig. 3, D and E). Collectively, results from a combination of gain- and loss-of-function experiments provide compelling evidence that Pitx2 is critical for initial induction of SMC differentiation marker genes in multipotential stem cells.
###end p 21
###begin p 22
###xml 92 97 92 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 0 127 0 127 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Induction of SMC differentiation marker genes is attenuated in embryoid bodies derived from <italic>Pitx2</italic> homozygous knockout ES cells.</bold>
###xml 146 151 146 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 175 180 175 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 264 269 264 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 304 309 304 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 454 468 454 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 470 479 466 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM22&#945;</italic>
###xml 485 489 477 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACLP</italic>
Induction of SMC differentiation marker genes is attenuated in embryoid bodies derived from Pitx2 homozygous knockout ES cells. (A) Genotyping of Pitx2 knockout ES cells. (B) Pitx2 knockout ES cells were stained with Oct4, Sox2, and SSEA-1. (C-E) Five independent Pitx2 homozygous knockout ES cells, two Pitx2 heterozygous knockout ES cells, and wild-type ES cells were induced to differentiate into SMCs in context of embryoid bodies, and expression of SM alpha-actin, SM22alpha, and ACLP was determined by real-time RT-PCR (C) and flow cytometry (D and E). Representative data from flow cytometry is shown in D. WT, wild-type; Het, heterozygous; KO, knockout. Values represent the mean +/- SEM from three independent experiments.
###end p 22
###begin title 23
Pitx2-induced expression of SMC differentiation marker genes via binding to a TAATC(C/T) element
###end title 23
###begin p 24
###xml 143 157 143 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 196 204 192 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 285 293 281 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 370 384 366 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 496 510 488 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 598 612 586 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 835 849 819 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 894 915 874 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">Hautmann et al., 1997</xref>
###xml 1201 1215 1181 1191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 1326 1334 1302 1310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 1409 1418 1385 1390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM22&#945;</italic>
###xml 1526 1535 1498 1503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM22&#945;</italic>
###xml 1542 1550 1510 1518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 C</xref>
###xml 1403 1408 <span type="species:ncbi:10090">mouse</span>
To determine the molecular mechanisms whereby Pitx2 induces expression of SMC differentiation marker genes, various mutation constructs of the SM alpha-actin promoter-enhancer-luciferase plasmid (Fig. 4 A) were cotransfected with Pitx2a expression plasmid into A404 cells. As shown in Fig. 4 B, Pitx2 induced the transcriptional activity of the full-length -2.6/+2.8-kb SM alpha-actin promoter-enhancer-luciferase construct by 5.4-fold and the activity of the deletion construct, the -155/+21-bp SM alpha-actin promoter-luciferase, by 4.5-fold. However, Pitx2-induced activation of the -125/+23-bp SM alpha-actin promoter-luciferase construct was only 2.1-fold, suggesting that the sequence from -155 to -125 bp contains cis-regulatory elements important for Pitx2-induced activity. We previously identified an ATTA element within the SM alpha-actin promoter at -145 bp as a Prx1 binding site (Hautmann et al., 1997). We noticed that this element was highly homologous to the Pitx2 consensus DNA binding element 5'-TAATC(C/T)-3' in the reverse orientation and therefore tested the effect of mutation of this element on the Pitx2 response. Results showed that mutation of the TAATCT element within the SM alpha-actin promoter-luciferase construct reduced the responsiveness to Pitx2 as compared with the wild-type counterpart (Fig. 4 B). A consensus TAATCC element is also located at -1071 bp within the mouse SM22alpha gene. Mutagenesis experiments revealed that this element was important for Pitx2-induced activation of the SM22alpha gene (Fig. 4 C).
###end p 24
###begin p 25
###xml 0 84 0 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2 induces SMC differentiation marker genes by binding to the TAATC(C/T) element.</bold>
###xml 116 130 116 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 345 359 341 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 368 377 360 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM22&#945;</italic>
###xml 562 564 548 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 643 657 629 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 933 947 915 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 952 961 930 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM22&#945;</italic>
###xml 1002 1011 976 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM22&#945;</italic>
Pitx2 induces SMC differentiation marker genes by binding to the TAATC(C/T) element. (A) Schematic structure of the SM alpha-actin promoter. CArG B, CArG A, and a TAATCC element are shown. (B and C) Luciferase assays were performed in A404 cells cotransfected with Pitx2a expression plasmid and the promoter-enhancer-luciferase construct of the SM alpha-actin (B) and SM22alpha (C) genes. Schematic representation of mutation constructs is shown on the left. Values represent the mean +/- SEM from three independent experiments. (D) EMSA was performed using the 32P-labeled double-stranded oligonucleotide containing the TAATCT element of the SM alpha-actin gene and nuclear extracts from undifferentiated and differentiated A404 cells. Antibodies for Pitx2 (P) or SRF (S) were used to test interference. Arrowhead indicates a labeled oligonucleotide-Pitx2 protein complex. (E) Association of Pitx2 with the TAATC(C/T) region of the SM alpha-actin and SM22alpha genes or the first intron region of the SM22alpha gene was determined by ChIP assays in undifferentiated A404 cells, differentiated A404 cells treated with RA for 2 d (early), and differentiated A404 cells treated with RA for 3 d followed by puromycin selection for 2 d (late). Values represent the mean +/- SEM from three independent experiments.
###end p 25
###begin p 26
###xml 61 75 61 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 232 246 228 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 479 487 471 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 939 953 931 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 958 967 946 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM22&#945;</italic>
###xml 1018 1027 1002 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM22&#945;</italic>
###xml 1085 1093 1065 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 E</xref>
To determine if Pitx2 binds to the TAATCT element within the SM alpha-actin promoter, electrophoresis mobility shift assays (EMSA) were performed using the double-stranded oligonucleotide corresponding to the -156 to -131 bp of the SM alpha-actin promoter and nuclear extracts from A404 cells. The oligonucleotide containing the TAATCT element formed a slowly migrating complex with nuclear extracts from differentiated A404 cells but not those from undifferentiated A404 cells (Fig. 4 D). This complex was eliminated by cold-competitor oligonucleotide or by addition of an anti-Pitx2 antibody, demonstrating the specific Pitx2 binding to the TAATCT element. Binding of Pitx2 to the TAATC(C/T) element-containing regions of SMC differentiation marker genes was also examined by chromatin immunoprecipitation (ChIP) assays. Results showed that RA treatment induced the association of Pitx2 with the TAATC(C/T)-containing regions within the SM alpha-actin and SM22alpha genes but not with the first intron region of the SM22alpha gene, which lacks the TAATC(C/T) element, in A404 cells (Fig. 4 E). Pitx2 binding to these regions was decreased in later stages of differentiated A404 cells when expression of SMC differentiation marker genes was not dependent on Pitx2. Collectively, results provide evidence that binding of Pitx2 to the TAATC(C/T) element within the promoter-enhancer regions of SMC differentiation marker genes is required for induction of these genes during SMC differentiation.
###end p 26
###begin title 27
Pitx2 and SRF synergistically enhanced the transcriptional activity of SMC differentiation marker genes
###end title 27
###begin p 28
###xml 388 402 388 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 496 510 492 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 551 559 543 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 646 660 638 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 795 803 783 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 B</xref>
###xml 847 861 835 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 996 1010 980 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
Results thus far have shown that Pitx2 induces a subset of SMC differentiation marker genes that contain CArG elements within their promoter-enhancers. Thus, we tested the hypothesis that Pitx2 regulates SMC differentiation marker genes by interacting with the CArG-SRF complex. First, cotransfection experiments were performed using expression plasmids for Pitx2a and SRF as well as the SM alpha-actin promoter-luciferase construct. Results showed that Pitx2 and SRF synergistically induced the SM alpha-actin transcriptional activity in A404 cells (Fig. 5 A). Second, effects of mutation of the CArG elements on Pitx2-induced activation of the SM alpha-actin gene were tested in A404 cells. Mutation of CArG B, CArG A, or double mutation of CArGs B and A each decreased the response to Pitx2 (Fig. 5 B). These results suggest that Pitx2-induced SM alpha-actin transcription is mediated in part through the CArG-SRF complex. However, the TAATCT element was not required for SRF-induction of the SM alpha-actin gene (Fig. S4, available at ).
###end p 28
###begin p 29
###xml 0 70 0 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2 and SRF synergistically induce SMC differentiation marker genes.</bold>
###xml 188 202 188 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 370 384 366 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 1074 1088 1066 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
Pitx2 and SRF synergistically induce SMC differentiation marker genes. (A) Luciferase assays were performed in A404 cells cotransfected with expression plasmids for Pitx2a and SRF and the SM alpha-actin promoter-enhancer-luciferase construct. (B) Luciferase assays were performed in A404 cells cotransfected with Pitx2a expression plasmid and mutation constructs of the SM alpha-actin gene. (C) Coimmunoprecipitation assays were performed in COS cells cotransfected with SRF expression plasmid and wild-type Pitx2a expression plasmid or deletion mutants. Schematic representation of Pitx2a deletion constructs is shown (top). Numbers indicate the position of amino acids. (D) GST pulldown assays were performed using Myc-tagged Pitx2a protein and GST-SRF fusion protein or its deletion mutants. Asterisks indicate GST-SRF protein and its deletion mutants. (E) Mammalian two-hybrid assays were performed in Balb/c 3T3 cells. (F) A404 cells were infected with adenovirus expressing Pitx2a or empty adenovirus, and the association of SRF with the CArG-containing region of the SM alpha-actin gene was determined by ChIP assays. Values represent the mean +/- SEM of three independent experiments. Expression of SRF and GAPDH protein in A404 cells infected with adenovirus expressing Pitx2a or empty adenovirus are also shown.
###end p 29
###begin p 30
###xml 277 285 277 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 C</xref>
To determine if the synergistic effect of Pitx2 and SRF was caused by the direct interaction of these two proteins, coimmunoprecipitation assays were performed using expression plasmids for Flag-tagged Pitx2a and SRF. Interaction was readily detectable between Pitx2a and SRF (Fig. 5 C). The domain of Pitx2a required for SRF interaction was then determined by using Pitx2a deletion mutants. Although deletions from aa 101 to the carboxy terminus (Pitx2a [aa 1-208], Pitx2a [aa 1-189], and Pitx2a [aa 1-101]) did not affect SRF interaction, Pitx2a (aa 1-49), which lacked the homeodomain and the carboxy-terminal domain, failed to interact with SRF. In addition, although a deletion of the amino terminus to aa 38 (Pitx2a [aa 39-271]) did not affect SRF interaction, Pitx2a (aa 98-271), which lacked the homeodomain and the amino-terminal domain, did not exhibit SRF interaction. Moreover, a deletion mutant, Pitx2a (aa 39-100), which only contained the homeodomain, interacted with SRF, indicating that the homeodomain of Pitx2, which is common for all three Pitx2 isoforms, is sufficient for the physical interaction with SRF.
###end p 30
###begin p 31
###xml 279 287 279 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 D</xref>
###xml 434 442 434 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 E</xref>
###xml 661 686 661 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">Johansen and Prywes, 1993</xref>
The domain of SRF required for Pitx2 interaction was determined by GST pulldown assays and mammalian two-hybrid assays. Although the full-length SRF bound to Pitx2, neither SRF (aa 1-222) nor SRF (aa 1-132) truncation mutants bound to Pitx2 as determined by GST pulldown assays (Fig. 5 D). In support of this, results of mammalian two-hybrid assays showed that the domain of SRF from aa 266 to 414 was required for Pitx2 interaction (Fig. 5 E). Higher basal activities observed in GAL4-SRF (aa 168-508), GAL4-SRF (aa 266-508), and GAL4-SRF (aa 414-508) constructs may be caused by the lack of amino-terminal domain, which inhibits the activation domain of SRF (Johansen and Prywes, 1993). Collectively, these results suggest that the homeodomain of Pitx2 (aa 39-100) directly binds to the carboxy-terminal domain (aa 266-414) of SRF.
###end p 31
###begin p 32
###xml 185 207 185 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">Manabe and Owens, 2001</xref>
###xml 488 502 488 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 557 565 553 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 F</xref>
Because results of our previous studies showed that SRF was associated with CArG elements of SMC differentiation marker genes in differentiated, but not in undifferentiated A404 cells (Manabe and Owens, 2001), we tested if Pitx2 alters the binding affinity of SRF with CArG elements of SMC differentiation marker genes. Adenovirus-mediated overexpression of Pitx2 did not change SRF expression levels, but it greatly enhanced the association of SRF with the CArG-containing region of the SM alpha-actin promoter in A404 cells, as determined by ChIP assays (Fig. 5 F). Results suggest that Pitx2 induces expression of SMC differentiation marker genes, in part by interacting with SRF and increasing the association of SRF with the CArG elements within the promoter regions of SMC differentiation marker genes.
###end p 32
###begin title 33
Pitx2 induced acetylation of histone H4 at the promoter regions of SMC differentiation marker genes through the exchange of histone deacetylase (HDAC) 2 and HDAC5 with p300
###end title 33
###begin p 34
###xml 227 249 227 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">Manabe and Owens, 2001</xref>
###xml 436 452 436 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">Qiu and Li, 2002</xref>
###xml 454 474 454 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">Yoshida et al., 2007</xref>
###xml 987 1001 987 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 1022 1030 1018 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 A</xref>
###xml 1128 1142 1124 1134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 1206 1221 1198 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6, B and C</xref>
###xml 1274 1278 1266 1270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p300</italic>
###xml 1321 1335 1313 1323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 1342 1350 1330 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 C</xref>
###xml 1507 1521 1495 1505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 1595 1603 1579 1587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 D</xref>
Previous studies from our laboratory showed that RA-induced SMC differentiation in A404 cells was accompanied by the increase in the acetylation levels of histone H4 at the promoter regions of SMC differentiation marker genes (Manabe and Owens, 2001). The acetylation status of histones at the promoter regions of SMC differentiation marker genes has been shown to be regulated by the histone acetyltransferase p300 and multiple HDACs (Qiu and Li, 2002; Yoshida et al., 2007). We thus tested the hypothesis that changes in the histone acetylation status, through control of the balance between p300 and HDACs at the promoter regions of SMC differentiation marker genes, contribute to Pitx2-induced activation of SMC differentiation marker genes in A404 cells. This hypothesis was supported by the following experiments. First, results of ChIP assays showed that adenovirus-mediated overexpression of Pitx2 increased the acetylation levels of histone H4 within the promoter region of the SM alpha-actin gene in A404 cells (Fig. 6 A). Second, cotransfection experiments revealed that p300 enhanced Pitx2-induced activation of the SM alpha-actin gene, whereas HDAC2 and 5 markedly repressed it in A404 cells (Fig. 6, B and C). Third, siRNA experiments showed that knockdown of p300 decreased Pitx2-induced activation of the SM alpha-actin gene (Fig. 6 C). Finally, results of ChIP assays showed that adenovirus-mediated overexpression of Pitx2 increased the association of p300 with the promoter region of the SM alpha-actin gene, whereas it decreased the association of HDAC2 and 5 in A404 cells (Fig. 6 D). Collectively, these results suggest that Pitx2-induced activation of SMC differentiation marker genes is mediated, at least in part, through the exchange of HDAC2 and 5 with p300 at the promoter regions of SMC differentiation marker genes, which in turn results in increased acetylation levels of histone H4 and enhanced transcription of SMC differentiation marker genes.
###end p 34
###begin p 35
###xml 0 100 0 100 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2 induces acetylation of histone H4 at the promoter regions of SMC differentiation marker genes.</bold>
###xml 252 266 252 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 435 449 431 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 514 518 506 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p300</italic>
###xml 692 696 684 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p300</italic>
###xml 712 726 704 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 936 950 924 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
Pitx2 induces acetylation of histone H4 at the promoter regions of SMC differentiation marker genes. (A) A404 cells were infected with adenovirus expressing Pitx2a or empty adenovirus, and acetylation levels of histone H4 at the promoter region of the SM alpha-actin gene were determined by ChIP assays. (B) Luciferase assays were performed in A404 cells cotransfected with HDAC expression plasmids, Pitx2a expression plasmid, and the SM alpha-actin promoter-enhancer-luciferase construct. (C, left) Efficiency of p300 siRNA was tested by Western blotting. (C, right) Luciferase assays were performed in A404 cells cotransfected with Pitx2a expression plasmid, expression plasmid for p300 or p300 siRNA, and the SM alpha-actin promoter-enhancer-luciferase construct. (D) A404 cells were infected with adenovirus expressing Pitx2a or empty adenovirus, and the association of p300, HDAC2, and HDAC5 with the CArG-containing region of the SM alpha-actin gene was determined by ChIP assays. Values represent the mean +/- SEM of three independent experiments.
###end p 35
###begin title 36
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 30 34 <span type="species:ncbi:10090">mice</span>
Knockout of the Pitx2 gene in mice abolished expression of SMC differentiation markers in vessels during the early embryogenesis
###end title 36
###begin p 37
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 363 380 363 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">Gage et al., 1999</xref>
###xml 382 403 382 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">Kitamura et al., 1999</xref>
###xml 405 421 405 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">Lin et al., 1999</xref>
###xml 423 439 423 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">Lu et al., 1999a</xref>
###xml 581 586 581 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 624 629 624 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 757 762 749 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 811 818 803 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Figs. 7</xref>
###xml 823 824 815 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">8</xref>
###xml 862 870 850 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 C</xref>
###xml 875 883 863 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 C</xref>
###xml 900 908 884 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 F</xref>
###xml 1058 1063 1042 1047 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 1230 1235 1214 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 1260 1275 1244 1259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7, B and E</xref>
###xml 1281 1289 1265 1273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 B</xref>
###xml 1332 1347 1316 1331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7, A and D</xref>
###xml 1353 1361 1337 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 A</xref>
###xml 1417 1422 1401 1406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 1447 1466 1431 1450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7, G, I, and K</xref>
###xml 1472 1483 1456 1467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8, D&#8211;F</xref>
###xml 1576 1581 1560 1565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 1606 1617 1590 1601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7, M&#8211;O</xref>
###xml 1623 1634 1607 1618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8, J&#8211;L</xref>
###xml 1700 1705 1684 1689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 1724 1743 1708 1727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7, H, J, and L</xref>
###xml 1749 1760 1733 1744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8, G&#8211;I</xref>
###xml 1858 1863 1842 1847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 2102 2107 2078 2083 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 2173 2177 2149 2153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prx1</italic>
###xml 2284 2295 2256 2267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7, P&#8211;R</xref>
###xml 30 34 <span type="species:ncbi:10090">mice</span>
###xml 596 601 <span type="species:ncbi:10090">mouse</span>
###xml 630 634 <span type="species:ncbi:10090">mice</span>
###xml 772 777 <span type="species:ncbi:10090">mouse</span>
###xml 1245 1250 <span type="species:ncbi:10090">mouse</span>
###xml 1432 1437 <span type="species:ncbi:10090">mouse</span>
###xml 1533 1538 <span type="species:ncbi:10090">mouse</span>
###xml 1591 1596 <span type="species:ncbi:10090">mouse</span>
###xml 2117 2122 <span type="species:ncbi:10090">mouse</span>
###xml 2187 2192 <span type="species:ncbi:10090">mouse</span>
Knockout of the Pitx2 gene in mice has been shown to result in embryonic lethality by embryonic day (E) 14.5 because of multiple abnormalities, including the failure of ventral body wall closure, right pulmonary isomerism, altered cardiac positioning with valvular and atrial septation defects, and abnormal morphogenesis of the eyes, teeth, and pituitary gland (Gage et al., 1999; Kitamura et al., 1999; Lin et al., 1999; Lu et al., 1999a). To extend our preceding results from cultured cells to the in vivo circumstances, the role of Pitx2 in SMC differentiation was examined in Pitx2 knockout mouse embryos. Heterozygous Pitx2 mice were intercrossed, and expression of SMC differentiation markers, including SM alpha-actin and SM22alpha, was examined in Pitx2 knockout mouse embryos by immunohistochemistry (Figs. 7 and 8). Expression of both SM alpha-actin (Fig. 7 C and Fig. 8 C) and SM22alpha (Fig. 7 F) was virtually abolished in both the left and right sides of the third, fourth, and sixth branchial arch arteries and the dorsal aorta of homozygous Pitx2 knockout embryos at E11.5, as well as at E10.5 and 12.5 (not depicted). Expression of these SMC differentiation markers was also decreased in vessels of heterozygous Pitx2 knockout mouse embryos (Fig. 7, B and E; and Fig. 8 B), as compared with the wild-type embryos (Fig. 7, A and D; and Fig. 8 A). In contrast, expression of ACLP was not decreased in Pitx2 knockout mouse embryos (Fig. 7, G, I, and K; and Fig. 8, D-F). Pitx2 expression was seen in SMCs of wild-type mouse embryos, whereas it was abolished in Pitx2 knockout mouse embryos (Fig. 7, M-O; and Fig. 8, J-L). Expression of PECAM, an endothelial marker, was not altered in Pitx2 knockout embryos (Fig. 7, H, J, and L; and Fig. 8, G-I), suggesting that the formation of the endothelial tube is not impaired and that deletion of the Pitx2 gene exhibits a selective effect on SMC differentiation rather than the general effects on vessel formation. At E13.5, expression of SMC differentiation markers, including SM alpha-actin and SM22alpha, was not decreased in any vessels in Pitx2 knockout mouse embryos (unpublished data). Moreover, analysis of Prx1 knockout mouse embryos revealed that SM alpha-actin expression was not decreased in any vessels at E11.5 (Fig. 7, P-R). These results suggest that Pitx2, but not Prx1, is required for the initial induction of SMC differentiation during early embryonic development but can be compensated by other factors at later developmental time points.
###end p 37
###begin p 38
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 0 105 0 105 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of SMC differentiation markers is nearly abolished in vessels of <italic>Pitx2</italic> knockout mouse embryos.</bold>
###xml 306 311 298 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 357 362 349 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 519 523 507 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prx1</italic>
###xml 553 557 541 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prx1</italic>
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
###xml 392 397 <span type="species:ncbi:10090">mouse</span>
###xml 571 576 <span type="species:ncbi:10090">mouse</span>
Expression of SMC differentiation markers is nearly abolished in vessels of Pitx2 knockout mouse embryos. (A-O) Expression of SM alpha-actin (A-C), SM22alpha (D-F), ACLP (G, I, and K), PECAM (H, J, and L), and Pitx2 (M-O) was examined by immunohistochemistry in wild-type (A, D, G, H, and M), heterozygous Pitx2 knockout (B, E, I, J, and N), and homozygous Pitx2 knockout (C, F, K, L, and O) mouse embryos at E11.5. (P-R) Expression of SM alpha-actin was examined by immunohistochemistry in wild-type (P), heterozygous Prx1 knockout (Q), and homozygous Prx1 knockout (R) mouse embryos at E11.5. III, third branchial arch artery; IV, fourth branchial arch artery; VI, sixth branchial arch artery; DA, dorsal aorta. Original magnification, 40x. Bars, 100 mum.
###end p 38
###begin p 39
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 0 105 0 105 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of SMC differentiation markers is nearly abolished in vessels of <italic>Pitx2</italic> knockout mouse embryos.</bold>
###xml 260 265 256 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 308 313 304 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
###xml 340 345 <span type="species:ncbi:10090">mouse</span>
Expression of SMC differentiation markers is nearly abolished in vessels of Pitx2 knockout mouse embryos. Expression of SM alpha-actin (A-C), ACLP (D-F), PECAM (G-I), and Pitx2 (J-L) was examined in the dorsal aorta of wild-type (A, D, G, and J), heterozygous Pitx2 knockout (B, E, H, and K), and homozygous Pitx2 knockout (C, F, I, and L) mouse embryos at E11.5. Original magnification, 400x. Bars, 20 mum.
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 11 17 11 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bicoid</italic>
###xml 181 198 181 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">Gage et al., 1999</xref>
###xml 200 221 200 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">Kitamura et al., 1999</xref>
###xml 223 239 223 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">Lin et al., 1999</xref>
###xml 241 257 241 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">Lu et al., 1999a</xref>
###xml 371 387 371 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">Liu et al., 2001</xref>
###xml 414 419 414 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 702 721 702 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">Semina et al., 1996</xref>
###xml 1169 1183 1169 1179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 1185 1194 1181 1186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM22&#945;</italic>
###xml 1200 1211 1192 1203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">h1-calponin</italic>
###xml 1237 1242 1229 1234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 1874 1888 1866 1876 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 1897 1906 1885 1890 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM22&#945;</italic>
###xml 2034 2045 2018 2029 <italic xmlns:xlink="http://www.w3.org/1999/xlink">h1-calponin</italic>
###xml 2075 2080 2059 2064 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 2319 2324 2303 2308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 2555 2576 2539 2560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">Hautmann et al., 1997</xref>
###xml 2578 2599 2562 2583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">Yoshida et al., 2004a</xref>
###xml 2602 2606 2586 2590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prx1</italic>
###xml 2788 2792 2772 2776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prx1</italic>
###xml 2794 2798 2778 2782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prx2</italic>
###xml 2803 2812 2787 2796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prx1/Prx2</italic>
###xml 2828 2850 2812 2834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">Bergwerff et al., 2000</xref>
###xml 428 433 <span type="species:ncbi:9606">human</span>
###xml 2028 2033 <span type="species:ncbi:10090">mouse</span>
###xml 2089 2093 <span type="species:ncbi:10090">mice</span>
###xml 2334 2339 <span type="species:ncbi:10090">mouse</span>
###xml 2822 2826 <span type="species:ncbi:10090">mice</span>
Pitx2 is a bicoid-related homeodomain transcription factor that plays a key role in the development of multiple organs, including the heart, lung, eyes, teeth, and pituitary gland (Gage et al., 1999; Kitamura et al., 1999; Lin et al., 1999; Lu et al., 1999a). In addition, the Pitx2c isoform has been shown to be a critical factor for directing the left-right asymmetry (Liu et al., 2001). Indeed, mutation of the Pitx2 gene in human causes Axenfeld-Rieger syndrome, an autosomal-dominant disorder characterized by ocular anterior chamber anomalies causing glaucoma, dental hypoplasia, craniofacial dysmorphism, umbilical stump abnormalities, and abnormal development of the heart and pituitary gland (Semina et al., 1996). As such, although it is clear that Pitx2 is required for proper embryonic development, the role and mechanisms by which Pitx2 influences differentiation of the vascular system were unclear. In the present studies, we provide several lines of evidence indicating that Pitx2 plays a key role in the initial induction of SMC differentiation. First, overexpression of Pitx2 induced expression of multiple SMC differentiation marker genes, including SM alpha-actin, SM22alpha, and h1-calponin, whereas knockout of the Pitx2 gene attenuated the induction of these SMC differentiation marker genes in multiple in vitro SMC differentiation model systems. Second, Pitx2-induced activation of SMC differentiation marker genes was mediated by a combination of mechanisms, including the following: the binding of Pitx2 to TAATC(C/T) cis-elements within the promoter regions of SMC differentiation marker genes; the interaction between Pitx2 and SRF; and Pitx2-mediated exchange of HDACs with p300 to increase the histone H4 acetylation levels at the promoter regions of SMC differentiation marker genes. It is of note that the TAATC(C/T) cis-elements within the SM alpha-actin and the SM22alpha promoters were shown to be functional, and a similar TAATCA sequence was found at +336 bp within the first intron of the mouse h1-calponin gene. Third, knockout of the Pitx2 gene in mice virtually abolished the initial induction of SMC differentiation markers in branchial arch arteries and the dorsal aorta during embryogenesis. Indeed, our demonstration of impaired induction of SMC differentiation markers in Pitx2 knockout mouse embryos provides the first evidence that a homeodomain protein regulates SMC differentiation in vivo. Although we previously showed that Prx1 plays a key role in angiotensin II-induced hypertrophy in cultured SMCs (Hautmann et al., 1997; Yoshida et al., 2004a), Prx1 knockout had no effect on expression of SMC differentiation markers at the same time point during embryogenesis. Moreover, no evidence of defective SMC differentiation was found in Prx1, Prx2, or Prx1/Prx2 knockout mice (Bergwerff et al., 2000). Collectively, our results provide evidence that Pitx2 and Prx1 may play complementary roles in modulating SMC differentiation marker gene expression but operate at different developmental stages.
###end p 41
###begin p 42
###xml 59 64 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 232 246 232 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 251 260 247 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM22&#945;</italic>
###xml 484 501 476 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">Chen et al., 2002</xref>
###xml 503 518 495 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">Du et al., 2003</xref>
###xml 520 540 512 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">Yoshida et al., 2003</xref>
###xml 977 982 969 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 1070 1079 1062 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myocardin</italic>
###xml 1166 1184 1158 1176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">Pipes et al., 2005</xref>
###xml 1262 1271 1254 1263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myocardin</italic>
###xml 1313 1330 1305 1322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">Long et al., 2007</xref>
###xml 1333 1342 1325 1334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myocardin</italic>
###xml 1479 1496 1471 1488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">Wang et al., 2001</xref>
###xml 1498 1513 1490 1505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">Du et al., 2003</xref>
###xml 1550 1568 1542 1560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">Pipes et al., 2005</xref>
###xml 1582 1591 1574 1583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myocardin</italic>
###xml 1720 1729 1712 1721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myocardin</italic>
###xml 2051 2065 2043 2053 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 2195 2209 2183 2193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 2220 2236 2204 2220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">Gan et al., 2007</xref>
###xml 2305 2319 2289 2299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 2398 2412 2378 2388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 2603 2617 2579 2589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 2703 2717 2675 2685 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 2897 2910 2865 2878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">Yoshida, 2008</xref>
###xml 1679 1683 <span type="species:ncbi:10090">mice</span>
###xml 2191 2194 <span type="species:ncbi:10116">rat</span>
###xml 2276 2291 <span type="species:ncbi:10090">transgenic mice</span>
Results of the present studies showed that knockout of the Pitx2 gene was associated with marked decreases in expression of SMC differentiation marker genes that contain multiple CArG elements in their promoter-enhancers, including SM alpha-actin and SM22alpha. Although several previous studies, including our own, have reported that the CArG-SRF-myocardin complex plays an important role in the regulation of CArG-containing SMC differentiation marker genes in differentiated SMCs (Chen et al., 2002; Du et al., 2003; Yoshida et al., 2003), our present results suggest a novel mechanism wherein the initial induction of CArG-containing SMC differentiation marker genes is dependent on a combination of Pitx2 and SRF rather than a combination of myocardin and SRF, based on the following observations. First, we showed that the induction of SMC differentiation marker genes was dramatically attenuated during SMC differentiation in the context of embryoid bodies derived from Pitx2 knockout ES cells, whereas our previous studies showed that homozygous knockout of the myocardin gene exhibited little effect on SMC differentiation in the same embryoid body system (Pipes et al., 2005). Second, although recent studies showed the transcriptional activity of the myocardin gene during early embryonic development (Long et al., 2007), myocardin mRNA was not readily detectable in vessels, including the descending aorta, until E12.5, as determined by in situ hybridization assays (Wang et al., 2001; Du et al., 2003). Third, results of recent studies (Pipes et al., 2005) showed that myocardin-null ES cells were able to differentiate into SMCs in the context of chimeric knockout mice that were generated by injection of myocardin-null ES cells into the wild-type blastocysts. As such, these findings support the hypothesis that the initial induction of SMC differentiation is not dependent on myocardin but is regulated through alternative molecular mechanisms including Pitx2 and SRF. It is of interest that results of our recent studies showed that SM alpha-actin expression during early stages of embryonic development is dependent on two MCAT elements located at -184 and -320 bp within rat SM alpha-actin promoter (Gan et al., 2007). Indeed, mutation of MCAT elements in transgenic mice harboring an SM alpha-actin promoter-enhancer-LacZ construct revealed that MCAT elements are required for SM alpha-actin expression at E10.5 and 12.5 but dispensable after E13.5 through adulthood. It is thus interesting to postulate that MCAT elements and their binding factor RTEF-1 may cooperatively regulate SM alpha-actin expression with Pitx2. However, Pitx2 effects on the transcriptional activity of the SM alpha-actin gene were not affected by mutation of MCAT elements (unpublished data). Moreover, MCAT elements are not present in the promoter regions of other SMC differentiation marker genes (Yoshida, 2008). Collectively, our results suggest that Pitx2 and RTEF-1/MCAT elements may regulate early induction of SMC differentiation markers through independent mechanisms.
###end p 42
###begin p 43
###xml 200 204 200 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MKL2</italic>
###xml 218 224 218 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MRTF-B</italic>
###xml 399 414 395 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">Li et al., 2005</xref>
###xml 416 431 412 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">Oh et al., 2005</xref>
###xml 953 979 946 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">Topouzis and Majesky, 1996</xref>
###xml 1167 1172 1160 1165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 1514 1534 1507 1527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">Evans and Gage, 2005</xref>
###xml 1536 1551 1529 1544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">Ai et al., 2006</xref>
###xml 1617 1622 1610 1615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 1665 1670 1658 1663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 1805 1820 1798 1813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">Ai et al., 2006</xref>
###xml 1872 1877 1865 1870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 2009 2029 2002 2022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">Evans and Gage, 2005</xref>
###xml 2210 2215 2203 2208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 234 238 <span type="species:ncbi:10090">mice</span>
###xml 673 678 <span type="species:ncbi:9031">chick</span>
###xml 1182 1187 <span type="species:ncbi:10090">mouse</span>
###xml 1632 1636 <span type="species:ncbi:10090">mice</span>
###xml 1887 1891 <span type="species:ncbi:10090">mice</span>
###xml 2225 2229 <span type="species:ncbi:10090">mice</span>
Results of recent studies have provided evidence for diversity in transcriptional control of SMC differentiation among cells derived from different embryological origins. For example, knockout of the MKL2 (also called MRTF-B) gene in mice resulted in defective formation of neural crest-derived branchial arch arteries and severe reduction in SM alpha-actin expression selectively in these vessels (Li et al., 2005; Oh et al., 2005). These defects were rescued by neural crest-specific restoration of MKL2/MRTF-B expression, suggesting that MKL2/MRTF-B plays a critical role in regulating differentiation of neural crest cells into SMCs. In addition, results of studies in chick embryos also showed the diversity in differentiation of SMCs among distinct embryological origins in that they showed differences in morphology, growth, and responsiveness to transforming growth factor beta between local mesoderm-derived SMCs and neural crest-derived SMCs (Topouzis and Majesky, 1996). However, our results suggest that Pitx2 is required for SMC differentiation in at least two distinct embryological sources of SMCs. Indeed, expression of SMC differentiation markers in Pitx2 knockout mouse embryos was abolished in neural crest-derived SMCs located at the third, fourth, and sixth branchial arch arteries, as well as in the mesoderm-derived SMCs present in the dorsal aorta. These findings are consistent with results of previous studies showing that Pitx2 functioned in tissues from multiple embryological origins (Evans and Gage, 2005; Ai et al., 2006). For example, studies using the cardiac second lineage-specific Pitx2 knockout mice showed that deletion of the Pitx2 gene in the cardiac second lineage, which was derived from mesoderm, caused severe defects in alignment of the cardiac outflow tract (Ai et al., 2006). In contrast, studies using neural crest-specific Pitx2 knockout mice revealed that Pitx2 expression in neural crest was required for optic stalk and ocular anterior segment development (Evans and Gage, 2005). As such, the function of Pitx2 is unlikely to be restricted to the single embryological origin. Further analyses of expression of SMC differentiation marker genes in conditional Pitx2 knockout mice will be required to better clarify the cell type-specific requirement of Pitx2 for SMC differentiation from different embryological origins.
###end p 43
###begin p 44
###xml 569 589 569 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">Yoshida et al., 2007</xref>
###xml 670 690 670 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">Kioussi et al., 2002</xref>
###xml 754 763 754 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cyclin D2</italic>
###xml 1022 1031 1019 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cyclin D2</italic>
###xml 1142 1162 1139 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">Kioussi et al., 2002</xref>
Our results provide evidence that Pitx2-induced activation of SMC differentiation marker genes is mediated, at least in part, by promoting exchange of HDAC2 and 5 with p300 within the promoter regions of SMC differentiation marker genes, thereby increasing acetylation levels of histone H4 and chromatin relaxation. Consistent with this model, we previously showed that platelet-derived growth factor BB-induced suppression of SMC differentiation marker genes was caused, in part, by HDAC-mediated hypoacetylation of histone H4 within these promoters in cultured SMCs (Yoshida et al., 2007). Pitx2-induced hyperacetylation of histones has also been reported previously (Kioussi et al., 2002). The studies showed that Pitx2 activated transcription of the cyclin D2 gene by increasing the acetylation levels of histone H4 at the gene promoter. They presented evidence that these changes were dependent on exchange of HDAC1 with p300, which was mediated through association of Pitx2 and Wnt-activated beta-catenin within the cyclin D2 promoter. In addition, the interaction between Pitx2 and p300 has been shown by coimmunoprecipitation assays (Kioussi et al., 2002), although it is possible that other factors are required for this interaction. During the embryonic development, SMCs have been shown to exhibit a high rate of proliferation while at the same time activating expression of SMC differentiation marker genes. It is interesting to speculate that Pitx2 may play a key role in regulating both of these processes by cooperating with distinct partner proteins such as beta-catenin and SRF, respectively.
###end p 44
###begin p 45
In summary, results of the present studies provide novel evidence that Pitx2 plays a critical role in the induction of SMC differentiation during the early embryogenesis. Further studies are needed to determine whether Pitx2 contributes to the pathophysiology of vascular diseases such as atherosclerosis, hypertension, and restenosis, where SMC phenotypic switching plays a key role.
###end p 45
###begin title 46
Materials and methods
###end title 46
###begin title 47
Plasmid constructs and siRNA duplexes
###end title 47
###begin p 48
###xml 17 31 17 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 74 88 70 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 126 140 118 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 199 219 187 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">Yoshida et al., 2003</xref>
###xml 221 226 209 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">2004a</xref>
###xml 411 425 399 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 481 502 465 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">Yoshida et al., 2004a</xref>
###xml 519 528 503 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM22&#945;</italic>
###xml 708 723 688 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">Li et al., 1996</xref>
###xml 800 806 780 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2a</italic>
###xml 1022 1040 1002 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">Ganga et al., 2003</xref>
###xml 1042 1058 1022 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">Liu et al., 2005</xref>
###xml 1102 1107 1082 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 1213 1233 1193 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">Yoshida et al., 2003</xref>
###xml 1266 1270 1246 1250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prx1</italic>
###xml 1272 1281 1252 1261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myocardin</italic>
###xml 1283 1287 1263 1267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MKL1</italic>
###xml 1293 1297 1273 1277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MKL2</italic>
###xml 1325 1345 1305 1325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">Yoshida et al., 2003</xref>
###xml 1347 1352 1327 1332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">2004a</xref>
###xml 1354 1358 1334 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">2007</xref>
###xml 1386 1391 1366 1371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 1396 1400 1376 1380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP</italic>
###xml 1706 1710 1686 1690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p300</italic>
###xml 2138 2159 2114 2135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">Yoshida et al., 2004a</xref>
###xml 0 3 <span type="species:ncbi:10116">Rat</span>
###xml 505 510 <span type="species:ncbi:10090">Mouse</span>
Rat -2.6/+2.8-kb SM alpha-actin promoter-enhancer-luciferase, -155/+21-bp SM alpha-actin promoter-luciferase, and -125/+23-bp SM alpha-actin promoter-luciferase constructs were described previously (Yoshida et al., 2003, 2004a). Mutations (TAATCT element at -145 bp, AGATTA to AGCAGT; CArG B at -112 bp, CCCTATATGG to AACTATATAA; and CArG A at -62 bp, CCTTGTTTGG to AATTGTTTAA) were introduced into -155/+21-bp SM alpha-actin promoter-luciferase construct as described previously (Yoshida et al., 2004a). Mouse 1343-bp SM22alpha promoter-luciferase construct was provided by L. Li (Wayne State University, Detroit, MI) and mutation (GGATTA to GGCCCA) was introduced at -1071 bp by site-directed mutagenesis (Li et al., 1996). An expression plasmid for Flag-tagged Pitx2a was constructed by inserting Pitx2a cDNA into pCMV7.1 3xFLAG vector (Sigma-Aldrich). Deletion constructs of Flag-tagged Pitx2a were made by PCR. Expression plasmids for Myc-tagged Pitx2a, Pitx2b, and Pitx2c isoforms and SRF were described previously (Ganga et al., 2003; Liu et al., 2005). A siRNA expression plasmid targeting all Pitx2 isoforms was constructed by inserting specific oligonucleotide (AGAAACCGCTACCCAGACA) into pMighty-Empty (Yoshida et al., 2003). siRNA expression plasmids for Prx1, myocardin, MKL1, and MKL2 were described previously (Yoshida et al., 2003, 2004a, 2007). siRNA duplexes targeting Pitx2 and EGFP were purchased from MWG Biotech. Expression plasmids for HDAC1-5 were provided by S.L. Schreiber (Harvard University, Cambridge, MA) and E. Seto (H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL). An expression plasmid for p300 was purchased from Millipore. A siRNA expression construct for p300, pSUPER-alphap300, was provided by D.K. Granner (Vanderbilt University, Nashville, TN). GST-tagged SRF expression plasmid and its deletion mutants were provided by B.P. Herring (Indiana University, Indianapolis, IN). Expression plasmids for GAL4-SRF and truncated mutants were provided by R. Prywes (Columbia University, New York, NY). Expression plasmid for VP16-Pitx2a fusion protein was constructed as previously described (Yoshida et al., 2004a).
###end p 48
###begin title 49
Cell culture, transient transfection, and adenovirus infection
###end title 49
###begin p 50
###xml 89 111 89 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">Manabe and Owens, 2001</xref>
###xml 184 204 184 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">Yoshida et al., 2003</xref>
###xml 500 520 500 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">Yoshida et al., 2003</xref>
A404 cells were cultured and induced to differentiate into SMCs as described previously (Manabe and Owens, 2001). 10T1/2 cells and NIH/3T3 cells were cultured as described previously (Yoshida et al., 2003). Transfection of DNA plasmids was performed by using FuGene6 (Roche). Replication-deficient adenovirus expressing Flag-tagged Pitx2a was generated and purified by ViraQuest Inc. Infection of adenovirus expressing Flag-Pitx2a or empty adenovirus was performed at 50 MOI as previously described (Yoshida et al., 2003).
###end p 50
###begin title 51
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
Generation of Pitx2 homozygous knockout ES cells
###end title 51
###begin p 52
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 84 100 84 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">Lu et al., 1999a</xref>
###xml 144 166 144 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">Mortensen et al., 1992</xref>
###xml 253 258 253 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 311 316 311 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 661 679 661 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">Sinha et al., 2004</xref>
To obtain Pitx2 homozygous knockout ES cells, Pitx2 heterozygous knockout ES cells (Lu et al., 1999a) were cultured with 2 mg/ml G418 for 21 d (Mortensen et al., 1992). After 21 d, 192 independent clones were picked up, and five clones were found to be Pitx2 homozygous knockout ES cells by PCR genotyping. Two Pitx2 heterozygous knockout ES cell clones that survived the selection protocol were also used for control. Pluripotency of these ES cells was confirmed by immunostaining of ES cell markers including Oct4, Sox2, and SSEA-1 (Millipore). Procedures for differentiation of ES cells into SMCs in the context of embryoid bodies were described previously (Sinha et al., 2004).
###end p 52
###begin title 53
Subtraction hybridization screen
###end title 53
###begin p 54
Subtraction hybridization screen was performed by using the PCR-select cDNA subtraction kit (BD Biosciences) according to the manufacturer's instruction.
###end p 54
###begin title 55
RT-PCR and luciferase assays
###end title 55
###begin p 56
###xml 130 144 130 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 146 155 142 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM22&#945;</italic>
###xml 157 168 149 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">h1-calponin</italic>
###xml 170 174 162 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACLP</italic>
###xml 176 188 168 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">smoothelin-B</italic>
###xml 190 199 182 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myocardin</italic>
###xml 201 205 193 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MKL1</italic>
###xml 207 211 199 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MKL2</italic>
###xml 213 217 205 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prx1</italic>
###xml 219 224 211 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PECAM</italic>
###xml 226 245 218 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cardiac &#945;-actin</italic>
###xml 247 253 235 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NeuroD</italic>
###xml 255 260 243 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH</italic>
###xml 266 283 254 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">18S ribosomal RNA</italic>
###xml 311 329 299 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">Sinha et al., 2004</xref>
###xml 331 335 319 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">2006</xref>
###xml 337 358 325 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">Yoshida et al., 2004a</xref>
###xml 359 360 347 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">b</xref>
###xml 362 366 350 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">2007</xref>
###xml 400 405 388 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 626 644 614 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">Ganga et al., 2003</xref>
###xml 705 725 693 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">Yoshida et al., 2003</xref>
Total RNA prepared from cultured cells was used for semiquantitative or real-time RT-PCR analyses. Primer and probe sequences for SM alpha-actin, SM22alpha, h1-calponin, ACLP, smoothelin-B, myocardin, MKL1, MKL2, Prx1, PECAM, cardiac alpha-actin, NeuroD, GAPDH, and 18S ribosomal RNA were described previously (Sinha et al., 2004, 2006; Yoshida et al., 2004a,b, 2007). Primer and probe sequences for Pitx2 were as follows: Pitx2 sense, 5'-GCCAGCCTGAGACTGAAAGC-3'; Pitx2 antisense, 5'-CTGCATACTGGCAAGCACTCA-3'; and Pitx2 probe, 5'-GATTTCTTCGCGAGTGGAC-3'. Sequences for Pitx2 isoform-specific primers were described previously (Ganga et al., 2003). Luciferase assays were performed as previously described (Yoshida et al., 2003).
###end p 56
###begin title 57
Western blotting and coimmunoprecipitation assays
###end title 57
###begin p 58
###xml 90 110 90 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">Yoshida et al., 2007</xref>
Western blotting and coimmunoprecipitation assays were performed as previously described (Yoshida et al., 2007). Antibodies used were as follows: SM alpha-actin (1A4; Sigma-Aldrich), SM22alpha (Abcam), GAPDH (Millipore), Flag (M2; Sigma-Aldrich), SRF (Santa Cruz Biotechnology, Inc.), and Pitx2 (provided by T. Hjalt, Lund University, Lund, Sweden).
###end p 58
###begin title 59
EMSA and ChIP assays
###end title 59
###begin p 60
###xml 44 64 44 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">Yoshida et al., 2003</xref>
###xml 251 271 251 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">Yoshida et al., 2007</xref>
###xml 517 531 517 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
###xml 538 560 534 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">Manabe and Owens, 2001</xref>
###xml 599 608 595 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM22&#945;</italic>
###xml 713 722 705 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM22&#945;</italic>
EMSA was performed as described previously (Yoshida et al., 2003) using a double-stranded oligonucleotide (5'-CACCCAGATTAGAGAGTTTTGTG-3') or a mutated oligonucleotide (5'-CACCCAGCAGTGAGAGTTTGTG-3'). ChIP assays were performed as previously described (Yoshida et al., 2007). Antibodies used were the following: SRF, Pitx2, acetyl histone H4 (Millipore), p300 (Santa Cruz Biotechnology, Inc.), HDAC2 (Invitrogen), and HDAC5 (Cell Signaling Technology). Real-time PCR was performed to amplify the promoter region of the SM alpha-actin gene (Manabe and Owens, 2001), the TAATCC-containing region of the SM22alpha gene (5'-TGGGATTAAAGGCGTGTGCCCA-3' and 5'-ATCCACTACAGCCAGCCTGGCT-3'), or the first intron region of the SM22alpha gene (5'-AAGAAGGTGAGGGGCTAAGTTC-3' and 5'-TATCCCAGGCTAGTCTGAAGGA-3').
###end p 60
###begin title 61
GST pulldown assays and mammalian two-hybrid assays
###end title 61
###begin p 62
###xml 162 178 162 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 207 208 207 208 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 231 232 228 229 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 840 861 819 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">Yoshida et al., 2004a</xref>
###xml 162 178 <span type="species:ncbi:562">Escherichia coli</span>
Myc-tagged Pix2a protein was translated in TnT Quick coupled transcription/translation system (Promega). GST-tagged SRF and its truncated mutants were induced in Escherichia coli by the addition of 0.5 mmol/l isopropyl-1-thio-beta-d-galactopyranoside for 1 h at 37degreesC. Lysates were prepared by sonicating bacterial pellets in PBS containing 10% glycerin. Cleared lysates were incubated with Glutathione Sepharose 4B beads (GE Healthcare) for 1 h at 4degreesC and washed three times with cold PBS containing 10% glycerin. Beads-protein complex was incubated with Myc-tagged Pitx2a protein for 2 h at 4degreesC and washed three times. Beads-bound proteins were eluted by boiling and analyzed by Western blotting with anti-Myc antibody (Santa Cruz Biotechnology, Inc.). Mammalian two-hybrid assays were performed as previously described (Yoshida et al., 2004a).
###end p 62
###begin title 63
Flow cytometry
###end title 63
###begin p 64
Embryoid bodies were washed with PBS and incubated with 1 mg/ml collagenase type IV and 0.125% trypsin for 20 min at 37degreesC. Cells were fixed in 2% PFA, permeabilized by ice-cold methanol, and incubated with FITC-conjugated SM alpha-actin antibody (Sigma-Aldrich) or FITC-conjugated IgG as a negative control. Cells were analyzed using a FACSCalibur dual-laser benchtop cytometer (BD Biosciences).
###end p 64
###begin title 65
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
Immunohistochemistry in mouse embryos
###end title 65
###begin p 66
###xml 13 18 13 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 18 21 18 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 28 44 28 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">Lu et al., 1999a</xref>
###xml 109 113 109 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prx1</italic>
###xml 155 171 155 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">Lu et al., 1999b</xref>
###xml 518 539 509 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">Yoshida et al., 2004b</xref>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 77 82 <span type="species:ncbi:10090">Mouse</span>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 196 200 <span type="species:ncbi:10090">mice</span>
###xml 251 256 <span type="species:ncbi:10090">mouse</span>
Heterozygous Pitx2+/- mice (Lu et al., 1999a) were purchased from the Mutant Mouse Regional Resource Center. Prx1 knockout mice were described previously (Lu et al., 1999b). Heterozygous knockout mice were intercrossed to generate homozygous knockout mouse embryos. Embryos were harvested, fixed in 10% neutral buffered formalin, and embedded into paraffin. Yolk sacs were used for genotyping. The 5-mum sections were deparaffinized, rehydrated, and stained with antibodies for SM alpha-actin, SM22alpha, Pitx2, ACLP (Yoshida et al., 2004b), and PECAM (BD Biosciences). Staining was visualized by DAB or the Vector Blue Alkaline Phosphatase Substrate kit (Vector Laboratories) and counterstained by nuclear FastRed, hematoxylin or methylgreen. Images were obtained using a microscope (Axioskop 2; Carl Zeiss, Inc.) and camera (SPOT; Diagnostic Instruments, Inc.). Animal protocols were approved by the University of Virginia Animal Care and Use Committee. E0.5 was defined as noon of the day a vaginal plug was detected after overnight mating.
###end p 66
###begin title 67
Online supplemental material
###end title 67
###begin p 68
###xml 268 273 268 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PECAM</italic>
###xml 275 294 275 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cardiac &#945;-actin</italic>
###xml 300 306 296 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NeuroD</italic>
###xml 339 344 335 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 375 380 371 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2</italic>
###xml 514 528 510 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM &#945;-actin</italic>
Fig. S1 shows growth rates of A404 cells infected with adenovirus expressing Pitx2 or control adenovirus. Fig. S2 shows involvement of MKL1, MKL2, and myocardin in Pitx2-induced activation of SMC differentiation marker genes in A404 cells. Fig. S3 shows expression of PECAM, cardiac alpha-actin, and NeuroD in embryoid bodies derived from Pitx2 homozygous knockout ES cells, Pitx2 heterozygous ES cells, and wild-type ES cells. Fig. S4 shows mutational effects of a TAATCT element on SRF-induced activation of the SM alpha-actin gene. Table S1 shows a list of genes preferentially expressed in RA-treated A404 cells as compared with undifferentiated A404 cells. Online supplemental material is available at .
###end p 68
###begin title 69
Supplemental Material
###end title 69
###begin title 70
[Supplemental Material Index]
###end title 70
###begin p 71
We thank Drs. Tord Hjalt, Stuart L. Schreiber, Edward Seto, Daryl K. Granner, B. Paul Herring, Li Li, and Ron Prywes for reagents and Rupande Tripathi, Mary E. McCanna, and Dominique L. Rose for technical assistance.
###end p 71
###begin p 72
This study was supported by National Institutes of Health Grants P01HL19242, R01HL38854, and R37HL57353 to G.K. Owens and by American Heart Association National Scientist Development Grant 0635253N to T. Yoshida.
###end p 72

